Date Hour Room Track
05th December,2018 2:00-3:30 pm Track 3

All of these non-dilutive financing sources are becoming increasingly numerous thanks to both the emergence of interest expressed by many trusts and foundations in financing innovative start-ups, and also to the many governmental schemes that are devoted to financing the first steps
of biotech start-ups. How do these sources of revenue lead to real leverage effect or create constraints for the companies? What types of constraints do they expose biotech
entrepreneurs to?

Speakers
Maya Merrell - FAST FORWARD LLC
Steve Poirier - MONOGENIC Pharmaceuticals
Fatima Sulaiman - Scleroderma & Raynaud’s UK

Continue your tour